Second Open Label Extension to Bridging Study CTBM100C2303

Clinical trial NCT01069705 · COMPLETED

Trial details

NCT number: NCT01069705
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Infections Pseudomonas Aeruginosa

Start date: 2010-02-12
Primary completion: 2012-03-19
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.